Jinque Luo
Impact in
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
Papers in
-
- Inflammasome and immune disorders 3
- Genomics, phytochemicals, and oxidative stress 2
- Peroxisome Proliferator-Activated Receptors 2
- Surgery 5
- Cholesterol and Lipid Metabolism 4
- Co-authors
- Yanni Xu (10 shared papers)Zheng Gen Jin (6 shared papers)Shuyi Si (9 shared papers)Suowen Xu (4 shared papers)Yufeng Xia (5 shared papers)Bei Tong (3 shared papers)Yannong Dou (4 shared papers)Yan Yang (3 shared papers)
- Journals
- Frontiers in Pharmacology (3 papers)Biochemical and Biophysical Research Communications (3 papers)International Immunopharmacology (2 papers)Arteriosclerosis Thrombosis and Vascular Biology (2 papers)Journal of Dairy Science (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Jinque Luo
28 papers receiving 602 citations
Jinque Luo's Hit Papers
Peers
Comparison fields: 5 of 88
- Geriatrics and Gerontology 54
- Biochemistry 29
- Immunology 75
- Molecular Medicine 16
- Molecular Biology 212
Countries citing papers authored by Jinque Luo
This map shows the geographic impact of Jinque Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinque Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinque Luo more than expected).
Fields of papers citing papers by Jinque Luo
This network shows the impact of papers produced by Jinque Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinque Luo. The network helps show where Jinque Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Jinque Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 72 | |
| 2 | 2022 | 63 | |
| 3 | A novel small-molecule PCSK9 inhibitor E28362 ameliorates hyperlipidemia and atherosclerosis Hit paper breakdown → | 2024 | 53 |
| 4 | 2015 | 53 | |
| 5 | 2018 | 34 | |
| 6 | 2024 | 33 | |
| 7 | 2023 | 31 | |
| 8 | 2019 | 31 | |
| 9 | 2016 | 29 | |
| 10 | 2018 | 28 | |
| 11 | 2024 | 25 | |
| 12 | 2016 | 24 | |
| 13 | 2024 | 21 | |
| 14 | 2020 | 16 | |
| 15 | 2018 | 12 | |
| 16 | 2019 | 11 | |
| 17 | 2025 | 10 | |
| 18 | 2017 | 10 | |
| 19 | 2024 | 10 | |
| 20 | 2018 | 9 |
About Jinque Luo
Jinque Luo is a scholar working on Molecular Biology, Surgery, Geriatrics and Gerontology, Pharmacology and Immunology, having authored 30 papers that have together received 606 indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (4 papers), Sirtuins and Resveratrol in Medicine (4 papers), Inflammasome and immune disorders (3 papers), Genomics, phytochemicals, and oxidative stress (2 papers), Cancer, Lipids, and Metabolism (2 papers), Lipid metabolism and biosynthesis (2 papers), Peroxisome Proliferator-Activated Receptors (2 papers) and Biochemical effects in animals (2 papers). The work is most often cited by research in Geriatrics and Gerontology (54 citations), Biochemistry (29 citations), Immunology (75 citations), Molecular Medicine (16 citations) and Molecular Biology (212 citations). Jinque Luo has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Yanni Xu, Zheng Gen Jin, Shuyi Si, Suowen Xu, Yufeng Xia, Bei Tong, Yannong Dou, Yan Yang, Huan Liu and Xiaoqian Wu. Their work appears in journals such as Frontiers in Pharmacology, Biochemical and Biophysical Research Communications, International Immunopharmacology, Arteriosclerosis Thrombosis and Vascular Biology and Journal of Dairy Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.